Free Trial

LAVA Therapeutics (LVTX) Institutional Ownership

LAVA Therapeutics logo
$1.57 +0.02 (+1.29%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.58 +0.00 (+0.32%)
As of 08/29/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)

Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$4.58M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$773.17K
Get LVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LVTX Institutional Buying and Selling by Quarter

LAVA Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/16/2025 Lepercq De Neuflize Asset Management LLC31,000$41K0.0%+34.8%0.118%
8/15/2025 Rangeley Capital LLC27,073$36K0.0%N/A0.103%
8/11/2025 BML Capital Management LLC1,970,610$2.60M2.0%+0.5%7.491%
5/14/2025 Bruce & Co. Inc.521,874$663K0.2%-32.4%1.984%
5/13/2025 Lepercq De Neuflize Asset Management LLC23,000$29K0.0%N/A0.087%
5/8/2025 XTX Topco Ltd24,307$31K0.0%N/A0.092%
5/7/2025 BML Capital Management LLC1,960,610$2.49M1.9%N/A7.453%
2/17/2025 Two Sigma Investments LP48,772$46K0.0%-52.5%0.186%
2/17/2025 Sanofi1,919,455$1.83M1.0%N/A7.301%
2/17/2025 Sphera Funds Management LTD.126,328$120K0.0%-13.7%0.481%
2/17/2025 BNP Paribas Financial Markets41,800$40K0.0%N/A0.159%
11/20/2024 Virtu Financial LLC19,103$32K0.0%N/A0.075%
11/15/2024 Sphera Funds Management LTD.146,457$243K0.0%-60.2%0.000%
11/14/2024 Walleye Capital LLC14,762$25K0.0%-42.5%0.000%
10/8/2024 Pathway Financial Advisors LLC102,500$170K0.0%+70.8%0.404%
8/12/2024 XTX Topco Ltd30,807$55K0.0%N/A0.122%
7/24/2024 Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000%
4/10/2024 Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000%
5/12/2023 Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650%
2/10/2023 PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197%
2/1/2023 Bank of Montreal Can89,600$530K0.0%N/A0.353%
11/14/2022 UBS Oconnor LLC75,000$343K0.0%N/A0.296%
10/28/2022 Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409%
8/16/2022 DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506%
8/15/2022 Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274%
2/14/2022 Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470%
11/15/2021 Point72 Asset Management L.P.123,911$734K0.0%N/A0.489%
11/15/2021 AXA S.A.229,121$1.36M0.0%+3.8%0.904%
11/12/2021 Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553%
8/17/2021 Woodline Partners LP86,904$946K0.0%-23.3%0.343%
8/17/2021 Millennium Management LLC138,831$1.51M0.0%-38.6%0.548%
8/16/2021 Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108%
8/13/2021 Geode Capital Management LLC12,997$141K0.0%N/A0.051%
8/11/2021 Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100%
8/10/2021 Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084%
8/2/2021 New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075%
(Data available from 1/1/2016 forward)

LVTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LVTX shares?

During the previous two years, 12 institutional investors and hedge funds held shares of LAVA Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($2.60M), Sanofi ($1.83M), Bruce & Co. Inc. ($663K), Pathway Financial Advisors LLC ($170K), Sphera Funds Management LTD. ($120K), Two Sigma Investments LP ($46K), and Lepercq De Neuflize Asset Management LLC ($41K).Learn more on LAVA Therapeutics' institutional investors.

Which institutional investors have been buying LAVA Therapeutics' stock?

The following institutional investors have purchased LAVA Therapeutics' stock in the last 24 months: BML Capital Management LLC ($1.97M), Sanofi ($1.92M), Pathway Financial Advisors LLC ($102.50K), XTX Topco Ltd ($55.11K), BNP Paribas Financial Markets ($41.80K), Lepercq De Neuflize Asset Management LLC ($31K), and Rangeley Capital LLC ($27.07K).

How much institutional buying is happening at LAVA Therapeutics?

Institutional investors have bought a total of 4,075,848 shares in the last 24 months. This purchase volume represents approximately $4.58M in transactions.

Which of LAVA Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Bruce & Co. Inc. ($250K), Sphera Funds Management LTD. ($241.25K), Two Sigma Investments LP ($53.99K), and Walleye Capital LLC ($10.91K).

How much institutional selling is happening at LAVA Therapeutics?

Institutional investors have sold a total of 556,161 shares in the last 24 months. This volume of shares sold represents approximately $773.17K in transactions.



This page (NASDAQ:LVTX) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners